You are here

  • Home
  • Archive
  • Volume 5, Issue Suppl 2
  • II-09 Immunologic properties of cutaneous lupus erythematosus (CLE) patients refractory to antimalarials compared to patients that respond to antimalarials

Article info

Article menu

Download PDFPDF

Innate Immunity
II-09 Immunologic properties of cutaneous lupus erythematosus (CLE) patients refractory to antimalarials compared to patients that respond to antimalarials
Free

Authors

  • Krisha Desai 1Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA PubMed articlesGoogle scholar articles
  • Majid Zeidi 1Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA PubMed articlesGoogle scholar articles
  • Hee Joo Kim 1Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA 3Department of Dermatology, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea PubMed articlesGoogle scholar articles
  • Victoria P Werth 1Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA PubMed articlesGoogle scholar articles

Citation

Desai K, Zeidi M, Kim HJ, et al
II-09 Immunologic properties of cutaneous lupus erythematosus (CLE) patients refractory to antimalarials compared to patients that respond to antimalarials
Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-lsm.108

Publication history

  • First published September 4, 2018.
Online issue publication 
May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions